Henry Schein (WBO:HSIC) ROCE %: 9.51% (As of Mar. 2026)

What is Henry Schein ROCE %?

Henry Schein WBO:HSIC +1.37% 73 ROCE % is 9.51% as of Mar. 2026. GuruFocus rates WBO:HSIC with a GF Score™ of 73/100 and a GF Value™ of €73.91 (Fairly Valued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Henry Schein's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.51%.

Henry Schein (WBO:HSIC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Henry Schein ROCE % Related Terms

Henry Schein ROCE % Historical Data

* Premium members only.

The historical data trend for Henry Schein's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henry Schein ROCE % Chart

Henry Schein Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

15.22

12.42

8.70

8.59

8.39

Henry Schein Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															9.46	7.97	8.61	8.65	9.51

73GF Score

Henry Schein Inc WBO:HSIC

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Henry Schein ROCE % Calculation

Henry Schein's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	583.282	/	( ( (9758.19 - 2676.865)	+	(9577.61 - 2756.712) )	/ 2 )
	=	583.282	/	( (7081.325	+	6820.898)	/ 2 )
	=	583.282	/	6951.1115
	=	8.39 %

Henry Schein's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	653.94	/	( ( (9577.61 - 2756.712)	+	(9777.96 - 2851.905) )	/ 2 )
	=	653.94	/	( ( 6820.898	+	6926.055 )	/ 2 )
	=	653.94	/	6873.4765
	=	9.51 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 9.51% mean?

Henry Schein (WBO:HSIC) has a ROCE % of 9.51% as of Mar. 2026.

Is Henry Schein's ROCE % too high?

Henry Schein's current ROCE % is 9.51%. The Medical Distribution industry median ROCE % is 9.22. Henry Schein's value of 9.51% is 3.1% above this industry median. Overall, Henry Schein has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Henry Schein's ROCE % compare to AHG and ACH?

Henry Schein's ROCE % of 9.51% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Henry Schein's value of 9.51% is 3.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Distribution company?

The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current ROCE % of 9.51% is 3.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current ROCE % is 9.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Henry Schein stock overvalued right now?

Based on GuruFocus' analysis, Henry Schein (WBO:HSIC) is currently considered Fairly Valued. The stock's GF Value™ is €73.91, compared to a current price of €74.00 — trading 0.1% above its estimated fair value. The current ROCE % is 9.51% and 3.1% above the Medical Distribution industry median of 9.22. Henry Schein's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Henry Schein (WBO:HSIC), the current ROCE % is 9.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henry Schein (WBO:HSIC) Overvalued in 2026?

Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued. The current stock price of €74.00 is trading 0.1% above its estimated GF Value™ of €73.91. GuruFocus considers Henry Schein to be Fairly Valued.

Key valuation signals for WBO:HSIC:

ROCE %: 9.51%
GF Value™: €73.91 vs. price of €74.00 (0.1% above fair value)
GF Score™: 73/100 with 8 warning signs
Industry Position: 3.1% above the Medical Distribution median

No single metric tells the full story. See the WBO:HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henry Schein Business Description

Industry Healthcare Medical Distribution

Comparable Companies AHG ACH EDAP YI COSM HKPD VNOV SNYR MCK COR CAH ASX:SIG SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP

Other Exchanges HSIC:USA 1HSIC:Italy 0L3C:UK HS2:Germany

Address 135 Duryea Road, Melville, NY, USA, 11747

Website https://www.henryschein.com

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

73GF Score

Get the complete analysis for WBO:HSIC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.00

Price

€73.91

GF Value

View WBO:HSIC Analysis

See ROCE % data for all stocks →